🔗 Share this article Individuals Coming Off Slimming Jabs Put On Pounds Far More Rapidly Compared to Those on Conventional Diets Weight management involves ongoing approaches. A recent study indicates that people who come off blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who stop conventional lifestyle plans. Findings released in a major health publication points out that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month upon discontinuation. "Individuals buying such treatments should be aware of the potential of rapid weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb. Such speed of recovery suggests a reversion to starting mass within about 18 months. Weighing Approaches The research, which reviewed dozens of trials involving thousands of patients, compared the results of these new drugs with conventional dieting. The team note that people who shed pounds through diet and exercise generally see a slower creep back—around 100 grams monthly—post-intervention. Understanding the Rapid Regain Doctors propose the way of the injections explains the accelerated regain. The injections imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness. "Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert. "Discontinuation of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely." An Ongoing Issue? Medical guidelines recommend the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications. Many experts contend that, given the likelihood of weight regain, the therapy is often life-long. This view is reinforced by drug manufacturers, who note that the results "highlight the long-term character of obesity," akin to managing diseases like hypertension. Patient Experiences People who have come off the jabs explain a intense resurgence of hunger. "It felt as if a trigger flipping and you're instantly starving," said an individual. This challenge is worsened if patients have not developed lasting dietary or behavioural modifications during therapy. Widespread Use Survey data show that millions of adults in the UK have used these injections in the last 12 months, with interest remaining high. Use is more common among females than men. The middle-aged age group shows the highest usage rates. A large proportion access the medications through private prescriptions rather than public health services. Ultimately, experts stress that while these medications are powerful tools for shedding pounds, they are not a permanent cure and long-term success hinges on combined lifestyle management.
Weight management involves ongoing approaches. A recent study indicates that people who come off blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who stop conventional lifestyle plans. Findings released in a major health publication points out that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month upon discontinuation. "Individuals buying such treatments should be aware of the potential of rapid weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb. Such speed of recovery suggests a reversion to starting mass within about 18 months. Weighing Approaches The research, which reviewed dozens of trials involving thousands of patients, compared the results of these new drugs with conventional dieting. The team note that people who shed pounds through diet and exercise generally see a slower creep back—around 100 grams monthly—post-intervention. Understanding the Rapid Regain Doctors propose the way of the injections explains the accelerated regain. The injections imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness. "Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert. "Discontinuation of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely." An Ongoing Issue? Medical guidelines recommend the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications. Many experts contend that, given the likelihood of weight regain, the therapy is often life-long. This view is reinforced by drug manufacturers, who note that the results "highlight the long-term character of obesity," akin to managing diseases like hypertension. Patient Experiences People who have come off the jabs explain a intense resurgence of hunger. "It felt as if a trigger flipping and you're instantly starving," said an individual. This challenge is worsened if patients have not developed lasting dietary or behavioural modifications during therapy. Widespread Use Survey data show that millions of adults in the UK have used these injections in the last 12 months, with interest remaining high. Use is more common among females than men. The middle-aged age group shows the highest usage rates. A large proportion access the medications through private prescriptions rather than public health services. Ultimately, experts stress that while these medications are powerful tools for shedding pounds, they are not a permanent cure and long-term success hinges on combined lifestyle management.